Skip to Content

Join the 'Infectious Hepatitis' group to help and get support from people like you.

Infectious Hepatitis News

Serious Infections Tied to Suicide Risk

Posted 10 Aug 2016 by Drugs.com

WEDNESDAY, Aug. 10, 2016 – People hospitalized for serious infections may face an increased risk of dying by suicide, and researchers suspect there's a biological reason for it. In a study of over 7 million people, Danish researchers found that those who'd been hospitalized for infections were 42 percent more likely to die of suicide compared to people with no history of serious infection. People hospitalized for HIV/AIDS or the liver infection hepatitis showed the highest risk – more than twice that of people without those diseases, the study found. Although the study couldn't prove a cause-and-effect link, the study authors and at least one other brain health expert think the increased risk of suicide after infection might not simply reflect the psychological impact of serious illness. Instead, infections might directly contribute to suicide risk by causing inflammation in the ... Read more

Related support groups: Depression, Major Depressive Disorder, Hepatitis C, HIV Infection, Postpartum Depression, Hepatitis B, Dysthymia, Seasonal Affective Disorder, Hepatitis A, Neurotic Depression, Depressive Psychosis, Chronic Active Hepatitis, Infectious Hepatitis

Hepatitis C Now Leading Infectious Disease Killer in U.S.

Posted 4 May 2016 by Drugs.com

WEDNESDAY, May 4, 2016 – The number of hepatitis C-linked deaths in the United States reached a record high in 2014, and the virus now kills more Americans than any other infectious disease, health officials report. There were 19,659 hepatitis C-related deaths in 2014, according to preliminary data from U.S. Centers for Disease Control and Prevention. Those tragically high numbers aren't necessary, one CDC expert said. "Why are so many Americans dying of this preventable, curable disease? Once hepatitis C testing and treatment are as routine as they are for high cholesterol and colon cancer, we will see people living the long, healthy lives they deserve," said Dr. Jonathan Mermin said in an agency news release. He directs the CDC's National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. If not diagnosed and treated, people with hepatitis C are at increased risk for liver ... Read more

Related support groups: Infections, Hepatitis C, Infectious Hepatitis

Hepatitis C Drugs Will 'Strain Budgets' at Current Prices: Study

Posted 16 Mar 2015 by Drugs.com

MONDAY, March 16, 2015 – New hepatitis C drugs promise cure rates above 90 percent, but could prove to be budget-busters for public and private health insurers, a new analysis finds. Recently approved drugs for chronic hepatitis C have been heralded as a breakthrough that could make the liver disease "rare" in the United States. But with prices topping $1,000 per pill, government and private insurers are balking – often putting limits on which patients qualify for coverage. Now two new studies in the March 16 Annals of Internal Medicine conclude that for individual patients, treatment with the pricey pills is "cost-effective." That's a calculation that takes into account the years of better health and quality of life people will likely enjoy. The bad news? One study estimates that state governments and insurers will have to dig up an extra $65 billion over five years to get the drugs ... Read more

Related support groups: Hepatitis C, Harvoni, Sovaldi, Sofosbuvir, Chronic Active Hepatitis, Infectious Hepatitis

Chinese Researchers Report Successful Hepatitis E Vaccine

Posted 4 Mar 2015 by Drugs.com

WEDNESDAY, March 4, 2015 – A new vaccine for hepatitis E provides protection from the virus for at least 4.5 years, according to Chinese researchers. Although hepatitis E is relatively rare in the United States, it's a leading cause of serious liver problems in the developing world. Hepatitis E is spread through contaminated water and through person-to-person contact, the researchers said. "The hepatitis E vaccine was licensed in China in 2011 and is the only hepatitis E vaccine in the world," said lead researcher Dr. Ning-Shao Xia, a professor in the department of biology at Xiamen University. What hasn't been known is how long the vaccine continues to offer protection against hepatitis E, the researchers said. "Hepatitis E is one of the most common causes of acute hepatitis. Outbreaks occur now and then in areas with poor sanitation. Hepatitis E is the most life-threatening disease ... Read more

Related support groups: Infectious Hepatitis

Smoking Tied to Risk for Hepatitis Return After Liver Transplant

Posted 27 Jul 2012 by Drugs.com

FRIDAY, July 27 – Current or previous smoking may increase the risk of hepatitis reinfection in people who have a liver transplant due to viral hepatitis, a new study suggests. This may be because tobacco in cigarettes lowers their immune system response, according to Dr. Mamatha Bhat, of McGill University in Montreal, and colleagues. For the study, the investigators analyzed data from 444 transplants conducted at the McGill University Health Center between 1990 and 2004. They found that the average "viral hepatitis-free survival time" was less than one year for smokers and more than four years for nonsmokers. The study was published in the July issue of the journal Liver Transplantation. "Our findings suggest that recurrence of viral hepatitis may be more frequent among liver transplant recipients who are active or former smokers," Bhat said in a journal news release. Encouraging ... Read more

Related support groups: Smoking, Organ Transplant, Infectious Hepatitis

Ask a Question

Further Information

Related Condition Support Groups

Hepatitis C, Hepatitis B, Hepatitis A, Chronic Active Hepatitis, Infectious Hepatitis with Coma, Viral Infection